Functional Liver Imaging Score to Predict Clinically Significant PHLF for Hepatocellular Carcinoma After Resection
Journal of Hepatocellular Carcinoma · 2025-07 · Volume 12 · 1483-1493
DOI: 10.2147/jhc.s511240 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hepatocellular Carcinoma, 2025-07. Verfasst von Xihua Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Radiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
To develop a model based on Functional Liver Imaging Score (FLIS) to estimate the risk of clinically significant post-hepatectomy liver failure (PHLF) for hepatocellular carcinoma (HCC) after resection. Patients and Methods: This retrospective study analyzed 885 patients with HCC who undergoing liver resection at our medical center between January 2017 and December 2021. Patients were randomly (7:3) assigned to development (n=620) or internal validation (n=265) cohorts. Univariable and multivariable logistic regression analyses were performed to identify independent risk factors for clinically significant PHLF, defined as grade B or C PHLF by the International Study Group of Liver Surgery. Predictive performance was assessed by the area under receiver operator characteristic curves (AUC).
Results
Clinically significant PHLF occurred in 7.7% of the development cohort and 7.2% of the internal validation cohort. Multivariate analysis identified FLIS, major resection and ALBI score as independent predictors of clinically significant PHLF, and a model combining these three variables predicted failure in the development cohort (AUC 0.746, 95% CI 0.673-0.820) and internal validation cohort (AUC 0.717, 95% CI 0.595-0.838). The same model also predicted mortality within 90 days after surgery in the development cohort (AUC 0.704, 95% CI 0.575-0.832) and internal validation cohort (AUC 0.717, 95% CI 0.586-0.848). In both cohorts, overall survival rate was significantly lower among patients whom the model placed at high risk of clinically significant PHLF than among those at low risk.
Conclusion
The combination of FLIS and other easily acquired clinical data may reliably predict clinically significant PHLF and mortality in hepatocellular carcinoma. Functional liver imaging score derived from gadoxetic acid-enhanced MRI can effectively and conveniently evaluate liver function. In this study, functional liver imaging score, major resection and ALBI score were significantly associated with clinically significant post-hepatectomy liver failure for hepatocellular carcinoma after resection. A model combining these factors reliably predicted clinically significant post-hepatectomy liver failure and 90-day mortality in our cohort.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departments of Radiology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China.
Zitieren
APA
Zheng, X., Zhang, Y., Huang, H., & Luo, N. (2025). Functional Liver Imaging Score to Predict Clinically Significant PHLF for Hepatocellular Carcinoma After Resection. Journal of Hepatocellular Carcinoma, Volume 12, 1483-1493. https://doi.org/10.2147/jhc.s511240
Vancouver
Zheng X, Zhang Y, Huang H, Luo N. Functional Liver Imaging Score to Predict Clinically Significant PHLF for Hepatocellular Carcinoma After Resection. Journal of Hepatocellular Carcinoma. 2025;Volume 12:1483-1493. doi:10.2147/jhc.s511240
BibTeX
@article{Zheng2025,
author = {Zheng, Xihua and Zhang, Yumin and Huang, Huiying and Luo, Ningbin},
title = {Functional Liver Imaging Score to Predict Clinically Significant PHLF for Hepatocellular Carcinoma After Resection},
journal = {Journal of Hepatocellular Carcinoma},
year = {2025},
volume = {Volume 12},
pages = {1483--1493},
doi = {10.2147/jhc.s511240}
}
EUVIMED